Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.
Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan JL, Bucy RP, Kostrikis LG, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison RT 3rd, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M.
Nat Med. 2000 Jan;6(1):76-81.PMID: 10613828 [PubMed - indexed for MEDLINE]Related articles